These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 61873)

  • 21. Experimental allergic encephalomyelitis in resistant and susceptible guinea pigs: in vivo and in vitro correlates.
    Lisak RP; Zweiman B; Kies MW; Driscoll B
    J Immunol; 1975 Feb; 114(2 Pt 1):546-9. PubMed ID: 47353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental allergic encephalomyelitis--clinical aspects and treatment].
    Błaszczyk B
    Postepy Hig Med Dosw; 1979; 33(1):77-88. PubMed ID: 86987
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunomorphological characteristics of experimental allergic encephalomyelitis induced by an encephalitogenic polypeptide].
    Zhitnukhin IuL; Khizhniak MG
    Biull Eksp Biol Med; 1987 Mar; 103(3):343-6. PubMed ID: 2435338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
    Panitch H; Ciccone C
    Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein.
    Fritz RB; Chou CH; McFarlin DE
    J Immunol; 1983 Mar; 130(3):1024-6. PubMed ID: 6185565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvanticity of synthetic polynucleotides for induction of experimental allergic encephalomyelitis in guinea pigs.
    Paterson PY; Drobish DG
    J Immunol; 1974 Dec; 113(6):1942-6. PubMed ID: 4139200
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoimmune diseases and thalidomide. II. Adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the rat.
    Goihman-Yahr M; Requena MA; Vallecalle-Suegart E; Convit J
    Int J Lepr Other Mycobact Dis; 1974; 42(3):266-75. PubMed ID: 4218599
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental autoimmune demyelinating diseases: experimental allergic encephalomyelitis and experimental allergic neuritis.
    Lisak RP; Behan PO
    Biomedicine; 1975 Mar; 22(2):81-7. PubMed ID: 55276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of bacterial adjuvants on typhoid fever during the evolution of allergic reactions of the nervous system].
    Kantchourine AK; Volinsky MY
    Ann Inst Pasteur (Paris); 1967 Oct; 113(4):599-605. PubMed ID: 4964409
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic remitting-relapsing experimental allergic encephalomyelitis induced in monkeys with homologous myelin basic protein.
    Shaw CM; Alvord EC; Hruby S
    Ann Neurol; 1988 Dec; 24(6):738-48. PubMed ID: 2462850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic effect of myelin basic protein and synthetic encephalitogenic peptide in guinea pigs with experimental allergic encephalomyelitis].
    Belik IaV; Terletskaia IaT; Kozulina EP; Syrovatskaia LP; Gershkovich AA
    Vopr Med Khim; 1978; 24(3):372-7. PubMed ID: 78577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
    Killen JA; Swanborg RH
    J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of acute experimental allergic encephalomyelitis in guinea pigs by prior transfer of suboptimal numbers of EAE-effector cells: induction of chronic EAE in whole tissue-sensitized guinea pigs.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):635-8. PubMed ID: 6172501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
    [No Abstract]   [Full Text] [Related]  

  • 36. Neural antigens and induction of myelination inhibition factor.
    Seil FJ; Kies MW; Bacon M
    J Immunol; 1975 Feb; 114(2 Pt 1):630-4. PubMed ID: 47359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-induced inhibition of experimental allergic encephalomyelitis. III. Localization of an inhibitory site distinct from the major encephalitogenic determinant of myelin basic protein.
    Swanborg RH
    J Immunol; 1975 Jan; 114(1 Pt 1):191-4. PubMed ID: 46241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
    Matsumoto Y; Kawai K; Tomita Y; Fujiwara M
    Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against experimental allergic encephalomyelitis with peptides derived from myelin basic protein: presence of intact encephalitogenic site is essential.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1976 Jul; 117(1):110-4. PubMed ID: 58930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids.
    Moore GR; Traugott U; Farooq M; Norton WT; Raine CS
    Lab Invest; 1984 Oct; 51(4):416-24. PubMed ID: 6207382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.